Orlucent Receives FDA Breakthrough Device Designation for Handheld Mole Imaging System
/PRNewswire/ -- Orlucent, Inc., a company focused on clinical assessment of suspicious moles, today announced the U.S. Food and Drug Administration (FDA) has...
Source: prnewswire.com